Literature DB >> 9872598

Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases.

T Kelly1, Y Yan, R L Osborne, A B Athota, T L Rozypal, J C Colclasure, W S Chu.   

Abstract

Breast cancer cell lines vary in invasive behavior and one highly invasive cell line (MDA-MB-231) proteolytically degrades extracellular matrix with invadopodia (Thompson et al. 1992, J Cell Physiol, 150, 534-44; Chen et al 1994, Breast Cancer Res Treat, 31, 217-26). Invadopodial proteolysis of extracellular matrix is thought to be necessary for invasion; however, this has not been demonstrated directly. To obtain such evidence, normal (HBL-100) and malignant (MCF-7, MDA-MB-231) breast cells were evaluated for invadopodial proteolysis of extracellular matrix and invasive behavior. We report that invadopodial proteolysis of immobilized fibronectin is positively correlated with invasion of cells into type I collagen gels. Moreover, reducing the proteolytic activity of invadopodia with the metalloproteinase inhibitor, batimastat (BB-94), also decreases invasion indicating that breast cancer cell invasion is dependent upon proteolytically active invadopodia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9872598     DOI: 10.1023/a:1006538200886

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  40 in total

1.  A latent Mr 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: a member of the collagenase family of enzymes.

Authors:  G E Davis; B M Martin
Journal:  Cancer Res       Date:  1990-02-15       Impact factor: 12.701

2.  Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells.

Authors:  Y E Shi; J Torri; L Yieh; A Wellstein; M E Lippman; R B Dickson
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

3.  Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.

Authors:  H Ueno; H Nakamura; M Inoue; K Imai; M Noguchi; H Sato; M Seiki; Y Okada
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

4.  Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer.

Authors:  S Wojtowicz-Praga; J Low; J Marshall; E Ness; R Dickson; J Barter; M Sale; P McCann; J Moore; A Cole; M J Hawkins
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

5.  Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.

Authors:  K Imai; E Ohuchi; T Aoki; H Nomura; Y Fujii; H Sato; M Seiki; Y Okada
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

6.  Expression of activated gelatinase in human invasive breast carcinoma.

Authors:  P D Brown; R E Bloxidge; E Anderson; A Howell
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

7.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.

Authors:  E W Thompson; S Paik; N Brünner; C L Sommers; G Zugmaier; R Clarke; T B Shima; J Torri; S Donahue; M E Lippman
Journal:  J Cell Physiol       Date:  1992-03       Impact factor: 6.384

Review 8.  Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review.

Authors:  P Basset; C Wolf; P Chambon
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 9.  Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy.

Authors:  W T Chen; C C Lee; L Goldstein; S Bernier; C H Liu; C Y Lin; Y Yeh; W L Monsky; T Kelly; M Dai
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Expression of transformation-associated protease(s) that degrade fibronectin at cell contact sites.

Authors:  W T Chen; K Olden; B A Bernard; F F Chu
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

View more
  30 in total

Review 1.  Physiology of angiogenesis.

Authors:  H Kurz
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  RNA-binding IMPs promote cell adhesion and invadopodia formation.

Authors:  Jonas Vikesaa; Thomas V O Hansen; Lars Jønson; Rehannah Borup; Ulla M Wewer; Jan Christiansen; Finn C Nielsen
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

3.  Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.

Authors:  Victoria J Christiansen; Kenneth W Jackson; Kyung N Lee; Patrick A McKee
Journal:  Arch Biochem Biophys       Date:  2006-11-17       Impact factor: 4.013

Review 4.  Redox signaling at invasive microdomains in cancer cells.

Authors:  Begoña Díaz; Sara A Courtneidge
Journal:  Free Radic Biol Med       Date:  2011-09-29       Impact factor: 7.376

5.  Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.

Authors:  Yan Huang; Avis E Simms; Anna Mazur; Sophie Wang; Noel R León; Barry Jones; Nazneen Aziz; Thomas Kelly
Journal:  Clin Exp Metastasis       Date:  2011-05-22       Impact factor: 5.150

6.  Diverse roles for the paxillin family of proteins in cancer.

Authors:  Nicholas O Deakin; Jeanine Pignatelli; Christopher E Turner
Journal:  Genes Cancer       Date:  2012-05

7.  Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells.

Authors:  Xiaolin Sun; Chenghai Li; Chunmei Zhuang; William C Gilmore; Everardo Cobos; Yunxia Tao; Zonghan Dai
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

8.  Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation.

Authors:  Begoña Diaz; Gidon Shani; Ian Pass; Diana Anderson; Manuela Quintavalle; Sara A Courtneidge
Journal:  Sci Signal       Date:  2009-09-15       Impact factor: 8.192

9.  Sample prep for proteomics of breast cancer: proteomics and gene ontology reveal dramatic differences in protein solubilization preferences of radioimmunoprecipitation assay and urea lysis buffers.

Authors:  Lambert C M Ngoka
Journal:  Proteome Sci       Date:  2008-10-24       Impact factor: 2.480

10.  Palladin contributes to invasive motility in human breast cancer cells.

Authors:  S M Goicoechea; B Bednarski; R García-Mata; H Prentice-Dunn; H J Kim; C A Otey
Journal:  Oncogene       Date:  2008-11-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.